The first comprehensive study of immune cell types in pre- and post-chemotherapy cancer tissues points up a host of targets for new or existing cancer drugs that could improve patients’ sensitivity to both chemotherapy and immunotherapy.
Read More
The first comprehensive study of immune cell types in pre- and post-chemotherapy cancer tissues points up a host of targets for new or existing cancer drugs that could improve patients’ sensitivity to both chemotherapy and immunotherapy.
Read More